{"id":37234,"date":"2018-05-29T09:00:00","date_gmt":"2018-05-29T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/"},"modified":"2024-07-29T08:01:25","modified_gmt":"2024-07-29T06:01:25","slug":"ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/","title":{"rendered":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership"},"content":{"rendered":"<p>Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center today announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by researchers in MD Anderson\u2019s Institute for Applied Cancer Science (IACS).<br \/>\nMD Anderson will progress the drug candidate through Phase I clinical development with Ipsen being responsible for further global development and commercialization.<br \/>\n<b>Alexandre Lebeaut, M.D., Executive Vice President, Research &amp; Development and Chief Scientific Officer, Ipsen,\u00a0<\/b>commented<em>, \u201cWe<\/em><em>\u00a0are very pleased to partner with the IACS at the MD Anderson Cancer Center whose reputation in scientific excellence and clinical care in Oncology is outstanding. Through this collaboration, we aim to synergize IACS\u2019 scientific expertise with Ipsen\u2019s drug development capabilities to deliver innovative therapies more rapidly to patients in need, and advance patient care in Oncology\u201d<\/em><br \/>\nMD Anderson and Ipsen also will collaborate to conduct additional pre-clinical studies to further explore the potential of the drug candidate\u2019s mode-of-action and expanded indications. The detailed financial terms of the agreement, including development and commercial milestones and royalties, have not been disclosed.<br \/>\n\u201cWe believe this partnership\u00a0<em>has the potential to deliver a new therapeutic option to our patients,\u201d<\/em>\u00a0said\u00a0<b>Stephen Hahn, M.D., chief medical executive at MD Anderson<\/b>.\u00a0<em>\u201cThis focus on accelerating the development of efficient treatments is vital to our mission of ending cancer and to providing the very best care we can to those who need it most.\u201d<\/em><\/p>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1763,1769,149],"tags":[],"class_list":["post-37234","press_release","type-press_release","status-publish","hentry","category-corporate-pressrelease","category-partnering-pressrelease","category-pressrelease","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-29T06:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership\",\"datePublished\":\"2018-05-29T07:00:00+00:00\",\"dateModified\":\"2024-07-29T06:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\"},\"wordCount\":256,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Corporate\",\"Partnering\",\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\",\"url\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\",\"name\":\"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-05-29T07:00:00+00:00\",\"dateModified\":\"2024-07-29T06:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership","og_url":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/","og_site_name":"Global","article_modified_time":"2024-07-29T06:01:25+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership","datePublished":"2018-05-29T07:00:00+00:00","dateModified":"2024-07-29T06:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/"},"wordCount":256,"publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Corporate","Partnering","Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/","url":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/","name":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-05-29T07:00:00+00:00","dateModified":"2024-07-29T06:01:25+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/37234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/37234\/revisions"}],"predecessor-version":[{"id":37628,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/37234\/revisions\/37628"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=37234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/categories?post=37234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/tags?post=37234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}